Clinical Trial Update: Multicentre SMS Study - FR

View source ↗

Summary

A multicentre clinical trial in France (SMS Study) by Medacta International SA is currently recruiting for hip-related conditions including developmental dyspla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Osteoarthritis of the Hip
• Traumatic Arthritis of the Hip

Snippet

Sponsor: Medacta International SA | Conditions: Dysplasia of Hip Joint, Hip Osteoarthritis | Status: RECRUITING